Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors

20158 citationsJournal Article

Authors

Good health and well-being

Published in: Investigational New Drugs

Volume 33, Issue 3, pp. 594-602

Field-Weighted Citation Impact: 0.85